A few studies reported that transcranial photobiomodulation was used to treat Parkinson's disease (PD), the positive effects of which were related to irradiating tyrosine hydroxylase positive (TH +) neurons in the substantia nigra pars compacta (SNc) to improve disabling dyskinesias [80–83]. This evidence concerns the gene TH and Parkinson disease.